Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.

An updated guideline for the management of dyslipidemia emphasized enhancing health-related behaviors and consideration of early initiation of lipid-lowering therapy, even in adults as young as 30 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The new guideline on managing dyslipidemia addresses the ...

Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

Following a second injection at eight weeks, the patient maintained stable vision and remained dry at 12 weeks, allowing for ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...